Icl Israel Chemicals Stock Price To Sales
| ICL Stock | USD 6.14 0.02 0.33% |
Fundamental analysis of ICL Israel allows traders to better anticipate movements in ICL Israel's stock price by examining its financial health and performance throughout various phases of its business cycle.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. ICL Israel Chemicals Company Price To Sales Analysis
ICL Israel's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current ICL Israel Price To Sales | 1.14 X |
Most of ICL Israel's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ICL Israel Chemicals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, ICL Israel Chemicals has a Price To Sales of 1.1398 times. This is 95.7% lower than that of the Chemicals sector and 43.29% lower than that of the Materials industry. The price to sales for all United States stocks is 90.02% higher than that of the company.
ICL Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ICL Israel's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ICL Israel could also be used in its relative valuation, which is a method of valuing ICL Israel by comparing valuation metrics of similar companies.ICL Israel is currently under evaluation in price to sales category among its peers.
ICL Fundamentals
| Return On Equity | 0.0689 | ||||
| Return On Asset | 0.0392 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.1 % | ||||
| Current Valuation | 10.09 B | ||||
| Shares Outstanding | 1.29 B | ||||
| Shares Owned By Insiders | 44.03 % | ||||
| Shares Owned By Institutions | 24.00 % | ||||
| Number Of Shares Shorted | 1.56 M | ||||
| Price To Earning | 918.89 X | ||||
| Price To Book | 1.32 X | ||||
| Price To Sales | 1.14 X | ||||
| Revenue | 6.84 B | ||||
| Gross Profit | 2.24 B | ||||
| EBITDA | 1.37 B | ||||
| Net Income | 407 M | ||||
| Cash And Equivalents | 516 M | ||||
| Cash Per Share | 0.40 X | ||||
| Total Debt | 2.29 B | ||||
| Debt To Equity | 0.51 % | ||||
| Current Ratio | 1.65 X | ||||
| Book Value Per Share | 4.66 X | ||||
| Cash Flow From Operations | 1.47 B | ||||
| Short Ratio | 2.06 X | ||||
| Earnings Per Share | 0.29 X | ||||
| Price To Earnings To Growth | 9.44 X | ||||
| Target Price | 6.61 | ||||
| Number Of Employees | 12 K | ||||
| Beta | 1.13 | ||||
| Market Capitalization | 7.92 B | ||||
| Total Asset | 11.32 B | ||||
| Retained Earnings | 5.76 B | ||||
| Working Capital | 1.26 B | ||||
| Current Asset | 2.98 B | ||||
| Current Liabilities | 2.05 B | ||||
| Annual Yield | 0.03 % | ||||
| Five Year Return | 3.55 % | ||||
| Net Asset | 11.32 B | ||||
| Last Dividend Paid | 0.17 |
About ICL Israel Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ICL Israel Chemicals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ICL Israel using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ICL Israel Chemicals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out ICL Israel Piotroski F Score and ICL Israel Altman Z Score analysis. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Fertilizers & Agricultural Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ICL Israel. If investors know ICL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ICL Israel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of ICL Israel Chemicals is measured differently than its book value, which is the value of ICL that is recorded on the company's balance sheet. Investors also form their own opinion of ICL Israel's value that differs from its market value or its book value, called intrinsic value, which is ICL Israel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ICL Israel's market value can be influenced by many factors that don't directly affect ICL Israel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ICL Israel's value and its price as these two are different measures arrived at by different means. Investors typically determine if ICL Israel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ICL Israel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.